Lauren Merendino
Director/Board Member at ESSA PHARMA INC.
Net worth: - $ as of 31/05/2024
Lauren Merendino active positions
| Companies | Position | Start | End |
|---|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2023 | - |
| ESSA PHARMA INC. | Director/Board Member | 06/06/2023 | - |
| Independent Dir/Board Member | 06/06/2023 | - |
Career history of Lauren Merendino
Former positions of Lauren Merendino
| Companies | Position | Start | End |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/09/2018 | 01/04/2021 |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Corporate Officer/Principal | 01/04/2021 | - |
| MYOVANT SCIENCES LTD. | Corporate Officer/Principal | 01/04/2021 | - |
Training of Lauren Merendino
| The Pennsylvania State University | Undergraduate Degree |
| New York University | Masters Business Admin |
Statistics
International
| United States | 6 |
| United Kingdom | 2 |
| Canada | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
| ESSA PHARMA INC. | Health Technology |
| Private companies | 3 |
|---|---|
Myovant Sciences Ltd.
 Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Lauren Merendino
- Experience
